China Shows Sharp Decline In Registration Approval Of Generic Drugs Last Year
This article was originally published in PharmAsia News
Last year, China's State FDA approved the registration applications of 651 generic drugs, constituting 73 percent of the year's approved 1,000 applications and dropping by 11 times from 2005, according to a recent SFDA conference on drug registration
You may also be interested in...
Ipsen’s business strategy calls for accessing external innovation across its pipeline, combined with geographic expansion, realizing the unmet potential of its marketed products and business efficiencies in manufacturing and operations.
The proposal, which would increase capacity for pandemic supplies, is similar to ideas President Trump embraced pre-pandemic.
Sanofi has named the head of its new API business; Sweden's Enzymatica has hired talent from J&J and L'Oreal; and Bayer has a new transformation officer.